USP1 deubiquitinates ID proteins to preserve a mesenchymal stem cell program in osteosarcoma

Samuel A Williams1, Heather L Maecker, Dorothy M French

  • 1Department of Physiological Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.

Cell
|September 20, 2011
PubMed

Insights

The deubiquitinating enzyme USP1 stabilizes Inhibitors of DNA binding (ID) proteins, maintaining stem cell characteristics in osteosarcoma. Targeting USP1 could offer a new therapeutic strategy for osteosarcoma differentiation therapy.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Stem Cell Biology

Background:

  • Inhibitors of DNA binding (ID) proteins are crucial for maintaining stem cell fate by inhibiting differentiation.
  • While ID proteins are typically degraded in differentiated tissues, they often persist in neoplasms.
  • The mechanisms regulating ID protein stability in cancer remain incompletely understood.

Purpose of the Study:

  • To investigate the role of the deubiquitinating enzyme USP1 in regulating ID protein stability.
  • To determine USP1's contribution to stem cell-like characteristics in osteosarcoma.
  • To explore USP1 as a potential therapeutic target for osteosarcoma.

Main Methods:

  • Immunoprecipitation and Western blotting to assess USP1-ID protein interactions and ubiquitination status.
  • USP1 knockdown and overexpression experiments in osteosarcoma and mesenchymal stem cells.
  • Assessment of cell proliferation, cell-cycle arrest, and osteogenic differentiation markers.
  • Analysis of USP1 and ID protein expression in primary human osteosarcoma samples.
  • Phenotypic analysis of USP1-deficient mice.

Main Results:

  • USP1 directly binds to and deubiquitinates ID1, ID2, and ID3, thereby stabilizing these proteins.
  • Co-overexpression of USP1 and ID proteins was observed in a subset of human osteosarcomas.
  • USP1 knockdown in osteosarcoma cells led to ID protein destabilization, cell-cycle arrest, and induced osteogenic differentiation.
  • Ectopic USP1 expression in mesenchymal stem cells promoted proliferation and inhibited osteoblastic differentiation.
  • USP1 deficiency in mice resulted in osteopenia, indicating its role in bone homeostasis.

Conclusions:

  • USP1 plays a critical role in stabilizing ID proteins, promoting stem cell-like properties in osteosarcoma.
  • USP1 is implicated in preserving the stem cell state characteristic of osteosarcoma.
  • USP1 represents a promising therapeutic target for inducing differentiation in osteosarcoma.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.